External broker reports(aggregated public sources), Prabhudas Lilladhar

Prabhudas Lilladhar

Prabhudas Lilladher is one of India's leading research based financial services organisation.  

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Prabhudas Lilladher is one of India's leading research based financial services organisation.

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Aster DM Healthcare Ltd / Equity Bottom-Up

<ul><li>Prabhudas Lilladher's research report on onAster DM Healthcare Our ASTER DM Healthcare (ASTERDM) India EBITDA stands increased by 4- 5% for FY25 and FY26 as we factor in higher operating margins.</li><li>This has been aided by gross margin expansion, occupancy scale up and faster ramp up in its Whitefield new unit.</li><li>ASTERDM India’s EBITDA increased sharply over last 3 years (30% CAGR over FY20-23) and growth momentum continued in FY24 with ~30% YoY growth.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Prabhudas Lilladher's research report on onAster DM Healthcare Our ASTER DM Healthcare (ASTERDM) India EBITDA stands increased by 4- 5% for FY25 and FY26 as we factor in higher operating margins.This has been aided by gross margin expansion, occupancy scale up and faster ramp up in its Whitefield new unit.ASTERDM India’s EBITDA increased sharply over last 3 years (30% CAGR over FY20-23) and growth momentum continued in FY24 with ~30% YoY growth.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Aster DM Healthcare - Margins to Scale Up; Re-Rating Candidate